Testosterone Lawsuits Move Forward, As Federal Court Sets Dates for First AndroGel Bellwether Trials, Bernstein Liebhard LLP Reports

January 13, 2016 (PRLEAP.COM) Business News
January 13, 2016 - Thousands of AndroGel lawsuits (http://www.rxinjuryhelp.com/testosterone-androgel/androgel/) and other testosterone claims are continuing to move forward in the federal multidistrict litigation now underway in the U.S. District Court, Northern District of Illinois. According to an Order dated December 10, 2015, up to a dozen AndroGel cases will be selected for the litigation's first bellwether trials, which will be convened on the following dates: April 21, 2017; June 5, 2017; July 10, 2017; August 21, 2017; September 25, 2017; and November 6, 2017. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

The cases selected for trial will be chosen from a list of 32 AndroGel lawsuits previously chosen by the parties. Discovery in those cases will be completed by March 23, 2016. By June 7, 2016, plaintiffs and the defense are to submit their proposals for the final bellwether selections. The Court will then designate up to 12 lawsuits to serve as bellwether trial cases by June 24, 2016.

"Our Firm is representing a number of testosterone plaintiffs who allegedly suffered serious cardiovascular events due to their use of AndroGel and other low-T therapies. The verdicts in the bellwether trials scheduled for next year could provide valuable insight into how juries might decide similar lawsuits," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by these medications.

Testosterone Litigation
Court documents indicate that nearly 3,500 testosterone lawsuits are now pending in the Northern District of Illinois against the manufacturers of AndroGel, Axiron, Testim and Androderm. All of the complaints were filed on behalf of men who allegedly suffered life-threatening or deadly heart attacks, strokes, deep vein thrombosis or pulmonary embolism due to their use of testosterone replacement medications. Plaintiffs claim that testosterone manufacturers concealed these risks and failed to provide doctors and patients with adequate warnings regarding the serious cardiovascular side effects associated with low-T therapy. They also accuse the drug makers of wrongly promoting their products as safe and effective treatments for men who experienced diminished testosterone levels merely as a result of the normal aging process, even though the medications were never approved for this purpose.

The litigation involving AndroGel and other low-T therapies began to grow shortly after the U.S. Food & Drug Administration (FDA) announced in January 2014 that it was reviewing the cardiovascular risks potentially associated with the use of testosterone replacement drugs. On March 3, 2015, the FDA ordered the manufacturers of prescription low-T therapies to update their labels with information regarding a potential association with an increased risk of heart attack and stroke. The FDA also directed that the labels clearly state that the drugs have not been proven safe and effective for treating low testosterone related to male aging.

Men who experienced serious cardiovascular events while using AndroGel, Axiron, Testim or Androderm may be entitled to compensation for their medicals bills and other injury-related damages. To learn more about pursuing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share Article